Regulation of dopamine D3 receptors by protein-protein interactions

Neuroscience Bulletin

Volumn 26, Issue 2, 2010, Pages 163-167

  Guo, Ming Lei ^a   Liu, Xian Yu ^a   Mao, Li Min ^a   Wang, John Q ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; CaMKII; Camp; Caudate; Cocaine; Phosphorylation; Striatum

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; DOPAMINE 3 RECEPTOR; ERYTHROCYTE BAND 4.1 PROTEIN; FILAMIN A; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 4; GLUTATHIONE TRANSFERASE; NEUROPEPTIDE; PARALEMMIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AUTOPHOSPHORYLATION; BINDING AFFINITY; BINDING SITE; HUMAN; LIMBIC SYSTEM; NERVE CELL; NUCLEUS ACCUMBENS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SHORT SURVEY;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP; HUMANS; LIMBIC SYSTEM; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, DOPAMINE D3; SIGNAL TRANSDUCTION;

EID: 77953505062     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-010-1016-y     Document Type: Short Survey

References (20)

1. Neve KA, Seamans JK, Trantham-Davidson H. Dopamine receptor signaling. J Recept Signal Transduct Res 2004, 24: 165-205.
2. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347: 146-151.
3. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 1991, 564: 203-219.
4. Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Rev 2005, 49: 77-105.
5. Sokoloff P, Diaz J, Le Foll B, Guillin O, Leriche L, Bezard E, et al. The dopamine D3 receptor: a therapeutic target for the treatment of neuorpsychiatric disorders. CNS Neurol Disord Drug Targets 2006, 5: 25-43.
6. Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc Natl Acad Sci U S A 2001, 98: 5258-5263.
7. Gorlin JB, Yamin R, Egan S, Stewart M, Stossel TP, Kwiatkowski D, et al. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol 1990, 111: 1089-1105.
8. Binda AV, Kabbani N, Lin R, Levenson R. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Mol Pharmacol 2002, 62: 507-513.
9. Walensky LD, Blackshaw S, Laio D, Watkins CC, Weier HU, Parra M, et al. A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1. J Neurosci 1999, 19: 6457-6467.
10. Kutzleb C, Sanders G, Yamamoto R, Wang X, Lichte B, Petrasch- Parwez E, et al. Paralemmin, a prenyl-palmitoyl-anchored phosphoprotein abundant in neurons and implicated in plasma membrane dynamics and cell process formation. J Cell Biol 1998, 143: 795-813.
11. Basile M, Lin R, Kabbani N, Karpa K, Kilimann M, Simpson I, et al. Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling. Arch Biochem Biophy 2006, 446: 60-68.
12. 2-like receptors. Mol Brain Res 2003, 117: 47-57.
13. Jeanneteau F, Diaz J, Sokoloff P, Griffon N. Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors. Mol Biol Cell 2004, 15: 696-705.
14. Fiorentini C, Busi C, Spano P, Missale C. Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function. Curr Opin Pharmacol 2009, 10: 1-6.
15. Villar VA, Jones JE, Armando I, Palmes-Saloma C, Yu P, Pascua AM, et al. G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem 2009, 284: 21425-21434.
16. Liu XY, Mao LM, Zhang GC, Papasian CJ, Fibuch EE, Lan HX, et al. Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII. Neuron 2009, 61: 425-438.
17. 2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 2002, 71: 473-510.
18. 2+-calmodulin-dependent protein kinases IV and II reveals shared and distinctive features. J Biol Chem 1998, 273: 3166-3179.
19. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 1997, 19: 837-848.
20. Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem Pharmacol 1992, 43: 659-666.